MedPath

Dexamethasone

Generic Name
Dexamethasone
Brand Names
Baycadron, Ciprodex, Decadron, Dexamethasone Intensol, Dextenza, Dioptrol, Hexadrol, Hidex 6-day Taper, Maxidex, Maxitrol, Neofordex, Ozurdex, Taperdex 12 Day Taper, Taperdex 6 Day Taper, Taperdex 7-day Taper, Tobradex, Zcort 7 Day Taper
Drug Type
Small Molecule
Chemical Formula
C22H29FO5
CAS Number
50-02-2
Unique Ingredient Identifier
7S5I7G3JQL
Background

Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Developed in 1957, it is structurally similar to other corticosteroids like hydrocortisone and prednisolone.

Dexamethasone was granted FDA approval on 30 October 1958. In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.

Indication

Dexamethasone and ciprofloxacin otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa. Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions. Oral tablets are indicated for the treatment of multiple myeloma. An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye. Various ophthalmic formulations are indicated for inflammatory conditions of the eye.

Associated Conditions
Acute Gouty Arthritis, Acute Leukemia, Acute Otitis Externa, Acute Otitis Media (AOM), Adrenocortical Hyperfunction, Adrenocortical Insufficiency, Allergic Conjunctivitis (AC), Alopecia Areata (AA), Ankylosing Spondylitis (AS), Aspiration Pneumonitis, Asthma, Atopic Dermatitis, Berylliosis, Bullous dermatitis herpetiformis, Bursitis, Chorioretinitis, Choroiditis, Congenital Adrenal Hyperplasia (CAH), Congenital Hypoplastic Anemia, Conjunctivitis, Contact Dermatitis, Cushing's Syndrome, Dermatitis, Diabetic Macular Edema (DME), Discoid Lupus Erythematosus (DLE), Drug hypersensitivity reaction, Edema of the cerebrum, Epicondylitis, Episcleritis, Erythroblastopenia, Eye Infections, Eye allergy, Glaucoma, Hypercalcemia, Immune Thrombocytopenia (ITP), Infection, Inflammation, Inflammation of the External Auditory Canal, Intraocular Inflammation, Iridocyclitis, Iritis, Keloids Scars, Keratitis, Lichen Planus (LP), Lichen simplex chronicus, Loeffler's syndrome, Lymphoma, Macular Edema, Meningitis caused by Mycobacterium Tuberculosis, Middle ear inflammation, Mucosal Inflammation of the eye, Multiple Myeloma (MM), Muscle Inflammation caused by Cataract Surgery of the eye, Mycosis Fungoides (MF), Necrobiosis lipoidica diabeticorum, Non-infectious Posterior Uveitis, Ocular Infections, Irritations and Inflammations, Ocular Inflammation, Ocular Inflammation and Pain, Ocular Irritation, Ocular Itching, Ophthalmia, Sympathetic, Optic Neuritis, Otitis Externa, Pemphigus, Perennial Allergic Rhinitis (PAR), Phlyctenular keratoconjunctivitis, Postoperative Infections of the eyes caused by susceptible bacteria, Posttraumatic Osteoarthritis, Regional Enteritis, Rheumatoid Arthritis, Rheumatoid Arthritis, Juvenile, Rosacea, Sarcoidosis, Scleritis, Seasonal Allergic Rhinitis, Secondary thrombocytopenia, Serum Sickness, Severe Seborrheic Dermatitis, Stevens-Johnson Syndrome, Synovitis, Systemic Lupus Erythematosus, Tenosynovitis, Trichinosis, Tuberculosis (TB), Ulcerative Colitis, Uveitis, Vernal Keratoconjunctivitis, Acquired immune hemolytic anemia, Acute rheumatic carditis, Anterior eye segment inflammation, Corticosteroid-responsive dermatoses, Ear infection-not otherwise specified caused by susceptible bacteria, Exfoliative erythroderma, Granuloma annulare lesions, Non-suppurative Thyroiditis, Ocular bacterial infections, Severe Psoriasis, Steroid-responsive inflammation of the eye, Swelling of the eyes, Varicella-zoster virus acute retinal necrosis, Watery itchy eyes
Associated Therapies
-

Expanded Access Program for Melphalan Flufenamide (Melflufen) in Triple Class Refractory Multiple Myeloma

Conditions
Relapsed and/or Refractory Multiple Myeloma
First Posted Date
2020-09-01
Last Posted Date
2021-03-18
Lead Sponsor
Oncopeptides AB
Registration Number
NCT04534322
Locations
🇺🇸

University of Illinois Cancer Center, Chicago, Illinois, United States

🇺🇸

Gabrail Cancer Center, Canton, Ohio, United States

🇺🇸

Texas Oncology, Dallas, Texas, United States

and more 8 locations

Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults

Phase 3
Recruiting
Conditions
B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
Interventions
Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration and Biopsy
Biological: Blinatumomab
Drug: Dasatinib
Drug: Cyclophosphamide
Drug: Cytarabine
Drug: Dexamethasone
Drug: Doxorubicin Hydrochloride
Procedure: Multigated Acquisition Scan
Drug: Ponatinib Hydrochloride
Procedure: Echocardiography
Procedure: Electrocardiography
Drug: Prednisone
Procedure: Lumbar Puncture
Drug: Methotrexate
Drug: Mesna
Drug: Vincristine Sulfate
First Posted Date
2020-08-28
Last Posted Date
2025-01-09
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
348
Registration Number
NCT04530565
Locations
🇺🇸

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States

🇺🇸

Anchorage Associates in Radiation Medicine, Anchorage, Alaska, United States

🇺🇸

Anchorage Radiation Therapy Center, Anchorage, Alaska, United States

and more 203 locations

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients

Not Applicable
Completed
Conditions
Pain Syndrome
Interventions
First Posted Date
2020-08-27
Last Posted Date
2022-02-18
Lead Sponsor
Minia University
Target Recruit Count
134
Registration Number
NCT04527770
Locations
🇪🇬

Mina Maher Raouf, ALMinya, Egypt

Toclizumam Versus Dexamethasone in Severe Covid-19 Cases

Not Applicable
Completed
Conditions
Pneumonia, Viral
Interventions
First Posted Date
2020-08-19
Last Posted Date
2020-08-25
Lead Sponsor
South Valley University
Target Recruit Count
69
Registration Number
NCT04519385
Locations
🇪🇬

Qena faculty medicine, Qinā, Egypt

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Early Phase 1
Active, not recruiting
Conditions
Lymphoma
Interventions
First Posted Date
2020-08-14
Last Posted Date
2024-02-26
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
37
Registration Number
NCT04514029
Locations
🇺🇸

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia

Phase 3
Completed
Conditions
Hypoxia
Covid19
Interventions
First Posted Date
2020-08-12
Last Posted Date
2022-02-24
Lead Sponsor
Scandinavian Critical Care Trials Group
Target Recruit Count
1000
Registration Number
NCT04509973
Locations
🇮🇳

Max Super Specialty Hospital, Saket, New Delhi, India

🇸🇪

Dept. of Anaesthesia and Intensive Care, Karolinska Universitetssjukhuset, Huddinge, Stockholm, Sweden

🇸🇪

Dept. of Infectious Diseases, Sahlgranska Universitetssjukhuset, Göteborg, Sweden

and more 50 locations

Intravenous Dexamethasone Administration in Patients Undergoing Total Shoulder Arthroplasty

Phase 4
Recruiting
Conditions
Arthroplasty, Replacement, Shoulder
Interventions
First Posted Date
2020-08-11
Last Posted Date
2023-09-07
Lead Sponsor
Christian Candrian
Target Recruit Count
74
Registration Number
NCT04507412
Locations
🇨🇭

Christian Candrian, Lugano, Switzerland

Leflunomide, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma

Phase 2
Recruiting
Conditions
Recurrent Plasma Cell Myeloma
Refractory Plasma Cell Myeloma
Interventions
First Posted Date
2020-08-11
Last Posted Date
2024-08-06
Lead Sponsor
City of Hope Medical Center
Target Recruit Count
29
Registration Number
NCT04508790
Locations
🇺🇸

City of Hope Medical Center, Duarte, California, United States

Olanzapine for the Prevention of Chemotherapy Induced Nausea and Vomiting in Gynecologic Oncology Patients

Phase 3
Terminated
Conditions
Gynecologic Cancer
Interventions
Drug: Ondansetron
Drug: Dexamethasone
Drug: Neurokinin-1 Receptor Antagonist (NK1-RA)
Drug: Olanzapine
Drug: Compazine
First Posted Date
2020-08-07
Last Posted Date
2024-06-10
Lead Sponsor
University of Michigan Rogel Cancer Center
Target Recruit Count
62
Registration Number
NCT04503668
Locations
🇺🇸

University of Michigan Rogel Cancer Center, Ann Arbor, Michigan, United States

Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19

Phase 3
Conditions
Covid19
ARDS
Interventions
First Posted Date
2020-08-05
Last Posted Date
2020-08-18
Lead Sponsor
Chattogram General Hospital
Target Recruit Count
60
Registration Number
NCT04499313
Locations
🇧🇩

Chattogram General Hospital, Chittagong, Bangladesh

🇧🇩

M. Abdur Rahim Medical College Hospital, Dinajpur, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath